- Home
- TLSI vs HYB Comparison
TLSI vs HYB Comparison
Compare TLSI & HYB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLSI
- HYB
- Stock Information
- Founded
- TLSI 2010
- HYB 1987
- Country
- TLSI United States
- HYB United States
- Employees
- TLSI N/A
- HYB N/A
- Industry
- TLSI Medical Specialities
- HYB Investment Managers
- Sector
- TLSI Health Care
- HYB Finance
- Exchange
- TLSI Nasdaq
- HYB Nasdaq
- Market Cap
- TLSI 166.8M
- HYB 194.0M
- IPO Year
- TLSI N/A
- HYB 1999
- Fundamental
- Price
- TLSI $4.95
- HYB $8.30
- Analyst Decision
- TLSI Strong Buy
- HYB
- Analyst Count
- TLSI 2
- HYB 0
- Target Price
- TLSI $14.00
- HYB N/A
- AVG Volume (30 Days)
- TLSI 66.5K
- HYB 39.6K
- Earning Date
- TLSI 08-14-2024
- HYB 01-01-0001
- Dividend Yield
- TLSI N/A
- HYB 6.67%
- EPS Growth
- TLSI N/A
- HYB N/A
- EPS
- TLSI N/A
- HYB N/A
- Revenue
- TLSI $24,736,000.00
- HYB N/A
- Revenue This Year
- TLSI $61.24
- HYB N/A
- Revenue Next Year
- TLSI $47.32
- HYB N/A
- P/E Ratio
- TLSI N/A
- HYB N/A
- Revenue Growth
- TLSI 67.75
- HYB N/A
- 52 Week Low
- TLSI $3.32
- HYB $6.23
- 52 Week High
- TLSI $10.42
- HYB $7.41
- Technical
- Relative Strength Index (RSI)
- TLSI 34.71
- HYB 79.03
- Support Level
- TLSI $4.80
- HYB $8.27
- Resistance Level
- TLSI $5.47
- HYB $8.41
- Average True Range (ATR)
- TLSI 0.33
- HYB 0.07
- MACD
- TLSI -0.05
- HYB -0.01
- Stochastic Oscillator
- TLSI 1.02
- HYB 82.86
About TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of innovative drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product lines Pressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.
About HYB New America High Income Fund Inc. (The)
New America High Income Fund Inc is a diversified, closed‐end management investment company. Its investment objective is to provide high current income while seeking to preserve stockholder capital by investing in a diversified portfolio of high-yield fixed-income securities. The Fund has a leveraged capital structure. The fund invests in fixed-maturity corporate debt securities that are rated less than the investment grade. Its portfolio of investment consists of investments in different sectors such as energy, financial, cable operators, healthcare, and others.